News & Updates

Treatment with pegcetacoplan improves the quality of life (QoL) of patients with paroxysmal nocturnal haemoglobinuria (PNH) who were naïve to complement inhibitor therapy, according to the PRINCE study update presented at EHA 2022. This comes with the added benefit of disease control.

Individuals with high body mass index (BMI) often eat delivery and takeaway meals, while those with low BMI and percent body fat usually consume homecooked meals, a UK study has found.

The association between proton pump inhibitor (PPI) use and increased cardiovascular disease risk, as seen in many observational studies, is probably caused by residual confounding related to conditions with PPI treatment instead of a true correlation, as suggested by negative findings in a self-controlled case series (SCCS) study.